(MedPage Today) — MONTREAL — Gene therapy for neovascular age-related macular degeneration (nAMD) achieved stable vision and retinal anatomy for up to 5 years, with dramatic reductions in treatment burden, according to studies reported here…
Source: MedPage Today — Headlines
